TrialInflammatory bowel diseases2016

Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.

Scott D Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.